JY
BIAF icon

Jeff Yass’s bioAffinity Technologies BIAF Stock Holding History

Jeff Yass’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Buy
+26,870
New +$54.9K ﹤0.01% 13026

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's BIAF Position: Q2 2026 in Review

Jeff Yass opened a new position in bioAffinity Technologies (BIAF) in Q2 2026: 26,870 shares worth $21.8K. The stake represents ﹤0.01% of the portfolio and ranks #13026 among its holdings.

19 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Jeff Yass held 26,870 shares of bioAffinity Technologies worth $21.8K as of Q2 2026.
  • bioAffinity Technologies was a new Jeff Yass position in Q2 2026.
  • bioAffinity Technologies made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13026 holding.
  • 19 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.